Drug and Medication Analysis & Statistics in Europe Countries, September 2014

You might be interested in: drug, vaccine, smoking cessation, more »

1-50 of about 1 500 reports

Purchase Reports From Reputable Market Research Publishers

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Latvia's disease profile and relatively low per-capita consumption of pharmaceuticals (compared with the rest of developed Europe) is a clear illustration of the need for innovative medicines. ...

  • Industries : Drug and Medication
  • Countries : Latvia
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lowe ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The short-term outlook for the Serbian pharmaceutical industry will continue to be clouded by corruption, debts accrued by the country’s health insurance ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Full-year trade data for 2011 and Q112 has confirmed that Moldova’s pharmaceutical industry has returned to more normal growth. However, with regional economic ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: We believe the pharmaceuticals and healthcare segment may be targeted by the government's 2011 cost-containment efforts following the successful implementation of austerity measures in 2010. ...

  • Industries : Drug and Medication
  • Countries : Spain
Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Russian pharmaceutical industry retains vast growth potential and the short- term environment is very positive for both domestic and foreign drugmakers. ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The UK faces its most uncertain period in a generation, as the Conservative-Liberal Democrat coalition presses ahead with fiscal cutbacks and constitutional reform. Plans to modernise the National ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Finland Pharmaceuticals and Healthcare Report Q3 2014

Finland Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Innovative drugmaker revenues will remain under threat in Finland. The Finnish government is committed to containing rising healthcare costs and despite company ...

  • Industries : Drug and Medication
  • Countries : Finland
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The period 2011-16 is projection to witness the proliferation of government initiatives supporting the growth of Switzerland's generic medicines industry, which ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The pharmaceutical industry in Belarus has significant long-term growth potential, but the country’s economy has entered a period of acute crisis and its long-deferred day of reckoning may ...

  • Industries : Drug and Medication
  • Countries : Belarus
Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Ukraine remains one of Central and Eastern Europe’s promising pharmaceutical industries, but its chronic lack of economic and political stability remains ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Our view that Slovenia’s drug industry is one of the most stable in the region remains in place despite the fact that - at the start of 2012 - the government ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Poland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Poland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite numerous challenges, we continue to believe Poland is the most attractive pharmaceutical industry in Central and Eastern Europe (CEE). While the long-awaited ...

  • Industries : Drug and Medication
  • Countries : Poland
Romania Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Although the fall of Romania’s government in a no-confidence vote in late April was a surprise, apart from changes in risk sentiment negatively affecting ...

  • Industries : Drug and Medication
  • Countries : Romania
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the recently appointed new heads at the Bulgarian Ministry of Health and the National Health Insurance Fund (NHIF) are now clearly looking at more aggressive ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Austria Pharmaceuticals and Healthcare Report Q3 2014

Austria Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Austria's economy is set to grow at a faster clip in the second half of 2014 and domestic consumer demand is poised to strengthen in this period. We have revised ...

  • Industries : Drug and Medication
  • Countries : Austria
Germany Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the increased consumption of generic medicines will have an impact on the overall pharmaceutical industry projection for Germany, we note that government ...

  • Industries : Drug and Medication
  • Countries : Germany
Italy Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We projection deteriorating prospects for drugmakers in Italy because in addition to a decline in public spending on pharmaceuticals (enforced by price cuts ...

  • Industries : Drug and Medication
  • Countries : Italy
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: As BMI warned it would back in February, the Hungarian government has announced deeper cuts to its pharmaceutical budget for this year and next. Our markedly ...

  • Industries : Drug and Medication
  • Countries : Hungary
Sweden Pharmaceuticals and Healthcare Report Q3 2014

Sweden Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Sweden is among the most attractive destinations for foreign investment within Europe. As one of the most advanced economies in the world, the country benefits ...

  • Industries : Drug and Medication
  • Countries : Sweden
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We stand by our negative projection for the Croatian pharmaceutical industry in 2012, on the back of the weakening economy and wide-ranging cost-containment ...

  • Industries : Drug and Medication
  • Countries : Croatia
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We have revised downwards our 2012 projections for the growth of the Latvian pharmaceutical industry on account of weaker growth towards the end of 2011, combined ...

  • Industries : Drug and Medication
  • Countries : Latvia
Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation ...

  • Industries : Drug and Medication
  • Countries : Greece
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Moldova’s pharmaceutical industry recorded stronger growth in 2011, but its small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Spain Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Firms with significant exposure to debt-ridden European industry s will be hard hit by government austerity measures across the region, particularly by pharmaceutical price erosion mechanisms. ...

  • Industries : Drug and Medication
  • Countries : Spain

2 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.